Bharathy et al. found that KAT2B was overexpressed in primary alveolar rhabdomyosarcoma, and its acetylation activated the PAX3-FOXO1 pathway and promoted carcinogenesis [38]. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.